Home Newsfeeds JP Morgan Downgrades ResMed to Neutral

JP Morgan Downgrades ResMed to Neutral

JP Morgan analyst David Low downgrades ResMed (NYSE:RMD) from Overweight to Neutral.

byBenzinga Newsdesk

August 12, 2022

1 minute read

JP Morgan analyst David Low downgrades ResMed (NYSE:RMD) from Overweight to Neutral.

Why Meta’s Social Media Peers Snap And Pinterest Are Plummeting Premarket Friday

By Shanthi Rexaline

April 28, 7:28 AM

Shares of Snap, Inc. (NYSE:SNAP) and Pinterest, Inc. (NYSE:PINS) were slumping in premarket trading, reacting to their respective…

Why SaaS Company Conduent’s Shares Are Rising Today

By Shivani Kumaresan

April 29, 10:09 AM

Conduent sees a surge in stock value following its partnership announcement with Microsoft. Leveraging Microsoft Azure OpenAI Service, Conduent aims to revolutionize healthcare claims management, customer service, and fraud detection, enhancing quality and productivity for global clients.

CNDT

Alset And 2 Other Stocks Under $2 Insiders Are Aggressively Buying

By Lisa Levin

July 3, 7:08 AM

The Dow Jones closed higher by over 280 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

AEI

Piper Sandler Maintains Neutral on Aurora Cannabis, Lowers Price Target to $3

By Benzinga Newsdesk

September 21, 6:38 AM

Piper Sandler analyst Michael Lavery maintains Aurora Cannabis (NASDAQ:ACB) with a Neutral and lowers the price target from $4 to $3.

ACB

JP Morgan Downgrades ResMed to Neutral

Related Posts

Why Meta’s Social Media Peers Snap And Pinterest Are Plummeting Premarket Friday

Why SaaS Company Conduent’s Shares Are Rising Today

Alset And 2 Other Stocks Under $2 Insiders Are Aggressively Buying

Piper Sandler Maintains Neutral on Aurora Cannabis, Lowers Price Target to $3